1. Home
  2. ZUMZ vs LUNG Comparison

ZUMZ vs LUNG Comparison

Compare ZUMZ & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

N/A

Current Price

$28.52

Market Cap

363.1M

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

N/A

Current Price

$2.51

Market Cap

63.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZUMZ
LUNG
Founded
1978
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.1M
63.6M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ZUMZ
LUNG
Price
$28.52
$2.51
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$18.00
$6.81
AVG Volume (30 Days)
313.5K
1.0M
Earning Date
12-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$916,909,000.00
$91,664,000.00
Revenue This Year
$5.50
$9.21
Revenue Next Year
$1.36
$5.03
P/E Ratio
$59.11
N/A
Revenue Growth
2.81
15.59
52 Week Low
$11.31
$1.31
52 Week High
$31.70
$9.37

Technical Indicators

Market Signals
Indicator
ZUMZ
LUNG
Relative Strength Index (RSI) 62.53 68.49
Support Level $28.55 $2.43
Resistance Level $29.68 $2.66
Average True Range (ATR) 1.19 0.20
MACD -0.04 0.07
Stochastic Oscillator 49.49 86.25

Price Performance

Historical Comparison
ZUMZ
LUNG

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: